Evelo Biosciences (EVLO) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free EVLO Stock Alerts $0.04 -0.01 (-18.67%) (As of 04/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineStock Traders Purchase High Volume of Evelo Biosciences Put Options (NASDAQ:EVLO)americanbankingnews.com - April 18 at 3:26 AMEvelo Biosciences Stock (OTC:EVLO), Short Interest Reportbenzinga.com - February 22 at 1:51 PMEvelo Biosciences, a microbiome company launched by Flagship, shuts downmsn.com - November 24 at 8:05 PMFlagship-backed startup Evelo, behind failed eczema drug, to dissolvebizjournals.com - November 22 at 2:45 PMFMR LLC Reduces Stake in Evelo Biosciences Incfinance.yahoo.com - November 14 at 8:21 PMEvelo Biosciences Inc EVLOmorningstar.com - November 10 at 10:48 PMQ3 2023 Horizon Technology Finance Corp Earnings Callfinance.yahoo.com - November 2 at 9:00 AMHorizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 2 at 9:00 AMEvelo Biosciences (EVLO) Price Target Increased by 53.85% to 10.20msn.com - November 1 at 7:20 PMTD Cowen Downgrades Evelo Biosciences (EVLO)msn.com - October 19 at 1:16 PMEvelo (EVLO) Drops 59% on Flunking Psoriasis Drug Studyfinance.yahoo.com - October 18 at 2:39 PMEvelo Biosciences Shares Down 58% After Unfavorable EDP2939 Resultsmarketwatch.com - October 17 at 5:41 PMHold Rating on Evelo Biosciences amid Unfavorable Outcomes and Strategic Changes: An Analyst Recommendation Reportmarkets.businessinsider.com - October 17 at 5:41 PMEvelo drops as mid-stage trial for psoriasis drug failsseekingalpha.com - October 17 at 12:40 PMEvelo Biosciences shares tank 46% after trial failureproactiveinvestors.com - October 17 at 12:40 PMEvelo Biosciences: EDP2939-101 Study Fails To Meet Endpoint; To Explore Strategic Alternativesmarkets.businessinsider.com - October 17 at 12:40 PMWhy Is Psoriasis Company Evelo Biosciences Stock Plunging Today?msn.com - October 17 at 12:40 PMmarketbeat.com - October 17 at 9:33 AMEvelo Biosciences Reviewing Alternatives After Study Didn't Meet Endpointmarketwatch.com - October 17 at 7:39 AMEvelo Biosciences to review options after Phase 2 trial of psoriasis treatment fails to meet main goalmarketwatch.com - October 17 at 7:39 AMEvelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasisfinance.yahoo.com - October 17 at 7:39 AMmarketbeat.com - October 17 at 6:56 AMEvelo Biosciences down 39% as 13M share offering beginsseekingalpha.com - August 18 at 12:41 PMmarketbeat.com - August 18 at 10:15 AMmarketbeat.com - August 18 at 9:36 AMEvelo Biosciences, Inc.: Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlightsfinanznachrichten.de - August 14 at 9:24 AMEvelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlightsfinance.yahoo.com - August 14 at 9:24 AMFMR LLC Acquires Significant Stake in Evelo Biosciences Incfinance.yahoo.com - August 11 at 2:54 AMMorgan Stanley Maintains Evelo Biosciences (EVLO) Equal-Weight Recommendationmsn.com - July 27 at 1:22 AMWhy Are velo Biosciences Stock Is Trading Higher Today?benzinga.com - July 21 at 12:48 PMWhy Are Evelo Biosciences Stock Is Trading Higher Today?benzinga.com - July 21 at 12:48 PMmarketbeat.com - July 21 at 9:42 AMInstrument Name Evelo Biosciences Inc Instrument Symbol (EVLO-Q)theglobeandmail.com - July 21 at 7:48 AMmarketbeat.com - July 18 at 11:55 AMEvelo Biosciences Closes $25.5 Million Private Placementfinance.yahoo.com - July 12 at 8:07 AMEvelo Biosciences shares are trading higher after the company announced a $25.5 million private placement.benzinga.com - July 11 at 10:15 AMEvelo Biosciences Shares Rise 20% After Private Offering Pricesmarketwatch.com - July 10 at 1:17 PMEvelo Biosciences Plans $25.5M Private Placement To Fund Psoriasis Trial, Pay Down Debtmsn.com - July 10 at 1:17 PMEvelo Biosciences Announces $25.5 Million Private Placementfinance.yahoo.com - July 10 at 8:17 AMEvelo Biosciences, Inc.: Evelo Biosciences Announces Reverse Stock Split Effectivefinanznachrichten.de - June 30 at 8:53 AMWhy Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionmsn.com - June 29 at 3:44 PMEvelo Biosciences Announces Reverse Stock Split Effectivefinance.yahoo.com - June 29 at 9:42 AMEVLO - Evelo Biosciences, Inc.finance.yahoo.com - June 22 at 12:44 AMWhy Is Evelo Biosciences (EVLO) Stock Up 51% Today?investorplace.com - June 20 at 10:06 AMEvelo Biosciences Granted U.S. Patent #11672834 For "PREBIOTIC COMPOSITIONS AND METHODS OF USE THEREOF FOR MODULATION OF THE MICROBIOME"benzinga.com - June 15 at 7:26 PMWhat Makes Evelo Biosciences, Inc. (EVLO) a New Buy Stockfinance.yahoo.com - May 17 at 3:00 PMEvelo Biosciences Insiders Added US$575k Of Stock To Their Holdingsfinance.yahoo.com - May 10 at 2:07 PMEvelo Biosciences Insiders Added US$575k Of Stock To Their Holdings \finance.yahoo.com - May 10 at 2:07 PMEvelo Biosciences (EVLO) Gets a Hold from Morgan Stanleymarkets.businessinsider.com - April 27 at 9:28 AMWhy Is Evelo Biosciences (EVLO) Stock Up 78% Today?investorplace.com - April 27 at 9:09 AM Get Evelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter. Email Address Incredible Opportunity to Retire FAST! (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide EVLO Media Mentions By Week EVLO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVLO News Sentiment▼0.320.48▲Average Medical News Sentiment EVLO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVLO Articles This Week▼21▲EVLO Articles Average Week Get Evelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NEPT News EVFM News SPRC News SXTC News BLPH News BDRX News BXRX News ADTX News ALLR News ATNF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVLO) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
